ALTERITY THERAPEUTICS LIMITED - AMERICAN DEPOSITAR
1.0700
22-November-24 16:44:58
15 minutes delayed
Stocks
0.0000
0.00%
Today's range
1.0010 - 1.1050
ISIN
N/A
Source
NASDAQ
-
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
26 Mar 2024 10:25:00 By Nasdaq GlobeNewswire
-
20 Feb 2024 10:25:00 By Nasdaq GlobeNewswire
-
06 Feb 2024 07:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
29 Jan 2024 07:24:00 By Nasdaq GlobeNewswire
-
22 Jan 2024 07:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
21 Dec 2023 00:30:00 By Nasdaq GlobeNewswire
-
04 Dec 2023 16:35:00 By Nasdaq GlobeNewswire
-
04 Dec 2023 07:25:00 By Nasdaq GlobeNewswire
-
27 Nov 2023 07:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
16 Nov 2023 07:25:00 By Nasdaq GlobeNewswire
-
08 Nov 2023 07:25:00 By Nasdaq GlobeNewswire
-
Appendix 4C – Q1 FY24 Quarterly Cash Flow Report
30 Oct 2023 07:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
31 Aug 2023 07:25:00 By Nasdaq GlobeNewswire
-
23 Aug 2023 07:25:00 By Nasdaq GlobeNewswire
-
22 Aug 2023 07:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund
15 Aug 2023 07:25:00 By Nasdaq GlobeNewswire
-
Appendix 4C – Q4 FY23 Quarterly Cash Flow Report
31 Jul 2023 07:52:00 By Nasdaq GlobeNewswire
-
26 Jul 2023 07:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Present in MST Access Rare Diseases, Rich Returns Forum on 22 June 2023
21 Jun 2023 07:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Initiates Second Phase 2 Study in Rare Parkinsonian Disorder
30 May 2023 07:25:00 By Nasdaq GlobeNewswire